药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02359 药明康德

未开盘 03-19 16:08:15

107.800

-2.400

-2.18%

最高109.600	最低107.000	成交量269.62万
今开107.900	昨收110.200	日振幅2.36%
总市值3,217亿	流通市值550.29亿	总股本29.84亿
成交额2.91亿	换手率0.53%	流通股本5.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":107.8,"timestamp":1773907695003,"preClose":110.2,"halted":0,"volume":2696199,"delay":0,"changeRate":-0.02177858439201457,"floatShares":510476909,"shares":2984000000,"eps":3.1042530692340233,"marketStatus":"未开盘","change":-2.4,"latestTime":"03-19 16:08:15","open":107.9,"high":109.6,"low":107,"amount":290914176,"amplitude":0.023593,"askPrice":107.9,"askSize":600,"bidPrice":107.8,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":6.022535430591286,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":0,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":110.2,"dividendRate":0.016866,"openAndCloseTimeList":[[1773883800000,1773892800000],[1773896400000,1773907200000]],"volumeRatio":0.879845991295916,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":91.58,"timestamp":1773903600000,"preClose":93.49,"halted":0,"volume":24071600,"delay":0,"premium":"+3.38"},"impliedVol":0.4653,"impliedVolPercentile":0.5122},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2620414038","title":"药明康德涨幅扩大至4.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620414038","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620414038?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:59","pubTimestamp":1773716350,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月17日，药明康德涨幅扩大至4.9%，报112.7港元，成交额1.5亿港元，总市值3354亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603173674291884.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674291884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1979443071.USD","LU1934453819.USD","LU1997244956.HKD","LU2495084118.USD","LU2125910500.SGD","02359","LU2045819591.USD","LU1808992512.USD","LU0052750758.USD","BK1576","LU2328871848.SGD","LU1046422090.SGD","LU1969619763.USD","LU0320764599.SGD","603259","LU1997245094.SGD","LU2242644610.SGD","LU0456842615.SGD","LU2488822045.USD","BK0216","LU1997245177.USD","LU0708995583.HKD","BK1583","BK1141"],"gpt_icon":0},{"id":"1117260775","title":"财报前瞻｜药明康德本季度营收预计增11.83%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1117260775","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117260775?lang=zh_cn&edition=full","pubTime":"2026-03-16 10:02","pubTimestamp":1773626555,"startTime":"0","endTime":"0","summary":"药明康德将于2026年03月23日盘后发布最新季度财报，市场预期营收与盈利延续同比增长，关注核心业务结构与盈利质量的变化。一致预期显示，本季度公司营收预计为人民币122.35亿元，同比增长11.83%；EBIT预计为人民币37.86亿元，同比增长20.22%；调整后每股收益预计为1.68元，同比增长39.42%。公司上季度实现营收人民币120.57亿元，同比增长15.26%；毛利率49.61%；归属于母公司股东的净利润人民币35.15亿元；净利率29.18%；调整后每股收益1.22元，同比增长54.43%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜药明康德本季度营收预计增11.83%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"gpt_icon":0},{"id":"2619785871","title":"每周股票复盘：药明康德（603259）将召开董事会审议2025年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619785871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619785871?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:49","pubTimestamp":1773514148,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，药明康德报收于90.87元，较上周的93.3元下跌2.6%。本周，药明康德3月11日盘中最高价报94.95元。药明康德当前最新总市值2711.34亿元，在医疗服务板块市值排名1/51，在两市A股市值排名47/5190。本周关注点来自公司公告汇总：药明康德将于2026年3月23日召开董事会会议，审议2025年度全年业绩及建议末期股息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0320764599.SGD","LU1997245177.USD","603259","LU0052750758.USD","LU1934453819.USD","BK1576","LU2328871848.SGD","BK0216","LU2125910500.SGD","LU0708995583.HKD","LU1969619763.USD","LU2488822045.USD","LU1997245094.SGD","LU1979443071.USD","BK1583","LU2495084118.USD","LU2045819591.USD","BK1141","LU1046422090.SGD","LU1997244956.HKD","LU1808992512.USD","LU2242644610.SGD","02359","LU0456842615.SGD"],"gpt_icon":0},{"id":"2618790414","title":"药明康德盘中异动 临近午盘大幅下跌3.10%报106.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618790414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618790414?lang=zh_cn&edition=full","pubTime":"2026-03-12 11:41","pubTimestamp":1773286872,"startTime":"0","endTime":"0","summary":"2026年03月12日临近午盘11时41分，药明康德股票出现异动，股价快速下跌3.10%。截至发稿，该股报106.400港元/股，成交量219.404万股，换手率0.43%，振幅4.28%。资金方面，该股资金流入1.09593亿港元，流出1.07343亿港元。最近的财报数据显示，该股实现营业收入359.88亿港元，净利润129.27亿港元，每股收益4.56港元，毛利165.60亿港元，市盈率31.43倍。药明康德股票所在的生物技术行业中，整体跌幅为2.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312114112a6b9aae7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312114112a6b9aae7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","BK1576","BK1141","LU0052750758.USD","02359","BK1583","LU0320764599.SGD","LU0708995583.HKD","LU2125910500.SGD","LU2045819591.USD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2618969049","title":"每日卖空追踪 | 药明康德 03月10日卖空量成交39.11万股，卖空比例为8.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618969049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618969049?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:30","pubTimestamp":1773131430,"startTime":"0","endTime":"0","summary":"药明康德北京时间03月10日，涨1.65%，卖空量成交39.11万股，较上一交易日减少69.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163405a45df81c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163405a45df81c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","02359","LU0052750758.USD","LU1046422090.SGD","BK1583","LU2045819591.USD","BK1576","BK1141","LU2242644610.SGD","LU0320764599.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2618067969","title":"药明康德盘中异动 早盘大幅上涨3.03%报112.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618067969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618067969?lang=zh_cn&edition=full","pubTime":"2026-03-10 09:33","pubTimestamp":1773106397,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时33分，药明康德股票出现异动，股价大幅上涨3.03%。截至发稿，该股报112.100港元/股，成交量42.3877万股，换手率0.08%，振幅2.85%。资金方面，该股资金流入1256.39万港元，流出1201.96万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体涨幅为1.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009331795466899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009331795466899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","BK1576","LU1046422090.SGD","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD","02359","LU0320764599.SGD","LU0052750758.USD","BK1583","BK1141"],"gpt_icon":0},{"id":"2618364193","title":"药明康德拟3月23日举行董事会会议批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2618364193","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618364193?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:32","pubTimestamp":1773045175,"startTime":"0","endTime":"0","summary":"格隆汇3月9日丨药明康德(02359.HK)宣布，将于2026年3月23日（星期一）召开董事会会议，以考虑及批准（其中包括）本集团截至2025年12月31日止年度全年业绩，及建议的末期股息（如有），以及处理任何其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163304a45ae6ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163304a45ae6ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0708995583.HKD","LU2125910500.SGD","LU2242644610.SGD","02359","LU0052750758.USD","BK1141","LU1046422090.SGD","LU2045819591.USD","BK1583","LU0320764599.SGD"],"gpt_icon":0},{"id":"2618264353","title":"药明康德盘中异动 早盘急速跳水3.21%报108.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618264353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618264353?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:30","pubTimestamp":1773019821,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时30分，药明康德股票出现异动，股价快速下挫3.21%。截至发稿，该股报108.400港元/股，成交量11.0152万股，换手率0.02%，振幅0.98%。资金方面，该股资金流入3.263万港元，流出135.367万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体跌幅为1.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093021a459a088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093021a459a088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2045819591.USD","BK1576","LU2125910500.SGD","BK1141","LU0320764599.SGD","LU0708995583.HKD","BK1583","LU2242644610.SGD","LU1046422090.SGD","02359"],"gpt_icon":0},{"id":"2617506348","title":"药明康德盘中异动 股价大涨3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617506348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617506348?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:12","pubTimestamp":1772763124,"startTime":"0","endTime":"0","summary":"2026年03月06日早盘10时12分，药明康德股票出现异动，股价大幅拉升3.13%。截至发稿，该股报111.900港元/股，成交量71.3316万股，换手率0.14%，振幅3.87%。资金方面，该股资金流入4050.31万港元，流出3235.43万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体涨幅为2.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306101204a6a8efb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306101204a6a8efb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","LU0320764599.SGD","LU1046422090.SGD","LU2242644610.SGD","BK1141","LU2125910500.SGD","LU0708995583.HKD","LU2045819591.USD","LU0052750758.USD","BK1583","BK1576"],"gpt_icon":0},{"id":"2617208528","title":"每日卖空追踪 | 药明康德 03月05日卖空量成交43.99万股，卖空比例为11.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617208528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617208528?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699431,"startTime":"0","endTime":"0","summary":"药明康德北京时间03月05日，跌0.37%，卖空量成交43.99万股，较上一交易日减少69.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163406a6a5d928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163406a6a5d928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","LU0052750758.USD","02359","LU1046422090.SGD","LU0320764599.SGD","LU2242644610.SGD","BK1141","LU0708995583.HKD","BK1576","BK1583","LU2045819591.USD"],"gpt_icon":0},{"id":"2617528267","title":"无锡药明康德新药开发股份有限公司发布2026年2月证券变动月报","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528267","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617528267?lang=zh_cn&edition=full","pubTime":"2026-03-05 00:50","pubTimestamp":1772643000,"startTime":"0","endTime":"0","summary":"中访网数据无锡药明康德新药开发股份有限公司于2026年3月4日向香港交易及结算所有限公司提交了截至2026年2月28日的证券变动月报表。报告显示，公司股本结构在报告期内保持稳定。公司已发行股本总额为人民币2,983,757,155元，由A股和H股构成。报告期内，公司未发生因股份期权、权证、可换股票据或其他协议安排导致的已发行股份或库存股份变动。公司亦确认，本月无香港预托证券的相关资料需披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305005121a44c0d65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305005121a44c0d65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","LU2045819591.USD","LU2242644610.SGD","LU0052750758.USD","02359","LU2125910500.SGD","BK1583","LU0708995583.HKD","BK1141","LU1046422090.SGD"],"gpt_icon":0},{"id":"1131679409","title":"摩根大通增持药明康德H股 持股比例从7.14%升至8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131679409","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131679409?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:13","pubTimestamp":1772619195,"startTime":"0","endTime":"0","summary":"根据香港交易所最新披露的数据，摩根大通于2月26日对药明康德H股（股份代号：02359）的持股比例出现显著变动。该机构持有的多头头寸从原先的7.14%提升至8.32%，显示出其对药明康德发展前景的持续看好。\n此次增持动作进一步巩固了摩根大通作为药明康德重要股东的地位。持股比例的提升往往被市场解读为机构投资者对企业基本面和未来成长潜力的积极预期。药明康德作为全球领先的医药研发外包服务平台，其业务布局和技术实力一直受到资本市场的广泛关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456842615.SGD","LU1808992512.USD","LU0320764599.SGD","LU2242644610.SGD","LU1046422090.SGD","LU1979443071.USD","LU2125910500.SGD","LU0708995583.HKD","LU1997244956.HKD","BK1576","LU2045819591.USD","BK1583","603259","BK0216","LU1997245177.USD","02359","LU2488822045.USD","LU2328871848.SGD","LU1969619763.USD","LU0052750758.USD","LU1997245094.SGD","LU1934453819.USD","LU2495084118.USD","BK1141"],"gpt_icon":0},{"id":"1183074387","title":"药明康德（02359）2月股份变动月报：股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1183074387","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183074387?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:54","pubTimestamp":1772614492,"startTime":"0","endTime":"0","summary":"无锡药明康德新药开发股份有限公司于2026年3月4日发布截至2026年2月28日的股份变动月报。公告显示，公司本月无新增发行、购回或注销股份活动，整体股本维持不变。报告期内，药明康德H股已发行股本数量为510,476,909股，A股已发行股本数量为2,473,280,246股，两类股份合计已发行股本总数为2,983,757,155股。公司在公告中确认，截至本月底继续符合香港联交所主板上市规则有关公众持股量的规定。总体来看，药明康德在2月期间股本结构保持稳定，未发生股份变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"gpt_icon":0},{"id":"2616587844","title":"药明康德盘中异动 股价大跌3.02%报109.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616587844","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616587844?lang=zh_cn&edition=full","pubTime":"2026-03-04 09:31","pubTimestamp":1772587898,"startTime":"0","endTime":"0","summary":"2026年03月04日早盘09时31分，药明康德股票出现异动，股价急速跳水3.02%。截至发稿，该股报109.000港元/股，成交量15.5947万股，换手率0.03%，振幅2.67%。资金方面，该股资金流入508.356万港元，流出402.801万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体跌幅为0.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603040931389542de1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603040931389542de1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2045819591.USD","BK1576","LU2125910500.SGD","BK1141","LU0320764599.SGD","LU0708995583.HKD","BK1583","LU2242644610.SGD","LU1046422090.SGD","02359"],"gpt_icon":0},{"id":"2616587848","title":"每日卖空追踪 | 药明康德 03月03日卖空量成交44.52万股，卖空比例为12.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616587848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616587848?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526631,"startTime":"0","endTime":"0","summary":"药明康德北京时间03月03日，跌2.43%，卖空量成交44.52万股，较上一交易日减少47.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163414a69cabf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163414a69cabf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","BK1576","LU1046422090.SGD","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD","02359","LU0320764599.SGD","LU0052750758.USD","BK1583","BK1141"],"gpt_icon":0},{"id":"2616311293","title":"药明康德：公司一直秉承“跟随科学、跟随客户、跟随分子”的战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2616311293","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616311293?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:09","pubTimestamp":1772453378,"startTime":"0","endTime":"0","summary":"证券日报网讯3月2日，药明康德在互动平台回答投资者提问时表示，公司多年来的持续增长来源于公司独特的一体化CRDMO业务模式，为全球客户提供兼具“质量、速度、成本”的解决方案，以及全球团队持续高效的执行力。公司一直秉承“跟随科学、跟随客户、跟随分子”的战略，通过公司独特的CRDMO业务模式，迅速产生行业洞见，前瞻性布局新能力，及时服务客户新分子需求，驱动公司长期发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603023658761843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1046422090.SGD","LU2495084118.USD","LU1934453819.USD","LU2488822045.USD","LU1969619763.USD","BK1583","LU1997244956.HKD","LU0320764599.SGD","603259","LU1997245177.USD","LU1979443071.USD","BK1576","02359","LU1997245094.SGD","LU0052750758.USD","LU2045819591.USD","LU0456842615.SGD","BK1141","LU0708995583.HKD","LU2242644610.SGD","LU1808992512.USD","LU2328871848.SGD","LU2125910500.SGD","BK0216"],"gpt_icon":0},{"id":"2616784879","title":"每周股票复盘：药明康德（603259）现大宗交易机构净买入254.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616784879","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616784879?lang=zh_cn&edition=full","pubTime":"2026-03-01 01:33","pubTimestamp":1772299990,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，药明康德（603259）报收于98.01元，较上周的101.91元下跌3.83%。本周，药明康德2月24日盘中最高价报103.88元。2月27日盘中最低价报97.18元。药明康德当前最新总市值2924.38亿元，在医疗服务板块市值排名1/51，在两市A股市值排名44/5189。本周关注点来自交易信息汇总：药明康德2月27日发生1笔大宗交易，机构净买入254.83万元交易信息汇总2月27日药明康德现1笔大宗交易，机构净买入254.83万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0320764599.SGD","BK1583","LU2488822045.USD","02359","LU0052750758.USD","LU2045819591.USD","BK1576","LU2328871848.SGD","LU2495084118.USD","BK1141","LU2242644610.SGD","LU1997245177.USD","LU0456842615.SGD","LU1979443071.USD","LU1808992512.USD","LU1997245094.SGD","LU0708995583.HKD","BK0216","LU1969619763.USD","LU1934453819.USD","LU1046422090.SGD","LU2125910500.SGD","603259","LU1997244956.HKD"],"gpt_icon":0},{"id":"2616827182","title":"医药生物行业周报：GSK联手中国新锐 SIRNA赛道布局再下一城","url":"https://stock-news.laohu8.com/highlight/detail?id=2616827182","media":"开源证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616827182?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"GSK 携手前沿生物加速布局siRNA，中国企业研发实力正获国际认可GSK 重点合作布局小核酸，已具有多款重磅管线。据Insight 统计，自2009 年起，GSK 已进行多起小核酸相关BD 交易，其中较多集中于ASO 和siRNA 领域。siRNA 领域，GSK 延续早期ASO 所布局的乙肝类管线协同性，与Arrowhead、WAVE 等企业在肝脏相关疾病领域着力布局。本周医药生物上涨0.5%，跑输沪深300 指数0.58pct，在31 个子行业中排名第25 位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301204231a43e2281&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301204231a43e2281&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02359","BK1161","BK1583","03759","01530","HK0000165453.HKD"],"gpt_icon":0},{"id":"2616826552","title":"医药行业周报：哮喘与COPD：长效化、生物药加速突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826552","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826552?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"核心观点：哮喘与COPD的异质性决定了2型炎症通路的精准分层与生物标志物驱动的个体化治疗是生物制剂价值兑现的前提；行业呈现“单靶点长效化”与“多靶点协同”的技术迭代趋势，同时COPD异质性催生出PDE3/4吸入制剂与生物制剂并行的双主线格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1161","06978","BK1574","02359","02269","BK1583","BK1576","03347"],"gpt_icon":0},{"id":"2614240835","title":"2月27日药明康德现1笔大宗交易 机构净买入254.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614240835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614240835?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:24","pubTimestamp":1772184268,"startTime":"0","endTime":"0","summary":"证券之星消息，2月27日药明康德发生大宗交易，交易数据如下：大宗交易成交价格98.01元，成交2.6万股，成交金额254.83万元，买方营业部为机构专用，卖方营业部为瑞银证券有限责任公司上海花园石桥路证券营业部。近三个月该股共发生62笔大宗交易，合计成交30.14万手，折价成交56笔，溢价成交1笔。截至2026年2月27日收盘，药明康德报收于98.01元，上涨0.0%，换手率0.95%，成交量23.51万手，成交额23.12亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700029042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0456842615.SGD","LU1808992512.USD","LU0320764599.SGD","LU2242644610.SGD","LU1046422090.SGD","LU1979443071.USD","LU2125910500.SGD","LU0708995583.HKD","LU1997244956.HKD","BK1576","LU2045819591.USD","BK1583","603259","BK0216","LU1997245177.USD","02359","LU2488822045.USD","LU2328871848.SGD","LU1969619763.USD","LU0052750758.USD","LU1997245094.SGD","LU1934453819.USD","LU2495084118.USD","BK1141"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1444},{"period":"3month","weight":0.0385},{"period":"6month","weight":-0.0227},{"period":"1year","weight":0.5417},{"period":"ytd","weight":0.0922}],"compareEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0074},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0294},{"period":"ytd","weight":-0.0051}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026724},{"month":2,"riseRate":0.5,"avgChangeRate":0.002978},{"month":3,"riseRate":0.375,"avgChangeRate":-0.020927},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038238}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}